glp 1 lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Ozempic® Lawsuit | July 2026

Late last year, Zepbound brought in $1.26 billion in the third quarter and $1.9 billion in the fourth quarter, which were lower than both company and analyst expectations

Hypoglycemia (in non-diabetic patients): Both medications: less than 1% Not a meaningful concern in patients without diabetes who are not taking insulin or sulfonylureas

AI: An enterprise AI model

The GLP-1RA group has reduced breath alcohol concentration (BrAC) and subjective feeling ratings during an alcohol administration session To understand the effects of GLP-1RAs on alcohol absorption and its subjective effects, we compared BrAC and subjective feelings of intoxication between groups